Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients

References

• Döhner H, Stilgenbauer S, Benner A, . Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343: 1910–1916.
   PubMed Web of Science ®Google Scholar
• Haferlach C, Dicker F, Schnittger S, . Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 2007;21:2442–2451.
   PubMed Web of Science ®Google Scholar
• Cuneo A, Bigoni R, Castoldi G. Towards a clinically relevant cytogenetic classification of chronic lymphocytic leukemia and related disorders. Haematologica 1998;83:577–579.
   PubMed Web of Science ®Google Scholar
• Nowell PC, Moreau L, Growney P, . Karyotypic stability in chronic B-cell leukemia. Cancer Genet Cytogenet 1988;33:155–160.
   PubMed Web of Science ®Google Scholar
• Juliusson G, Robèrt KH, Ost A, . Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. Blood 1985;65:134–141.
   PubMed Web of Science ®Google Scholar
• Cuneo A, Bigoni R, Rigolin GM, . Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. Haematologica 2002;87:44–51.
   PubMed Web of Science ®Google Scholar
• Chevallier P, Penther D, Avet-Loiseau H, . CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol 2002;116:142–150.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Witzig TE, Fink SR, . Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 2006;24: 4634–4634.
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S, Sander S, Bullinger L, . Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 2007;92:1242–1245.
   PubMed Web of Science ®Google Scholar
• Hjalmar V, Hast R, Kimby E. Sequential fluorescence in situ hybridization analyses for trisomy 12 in chronic leukemic B-cell disorders. Haematologica 2001;86:174–180.
   PubMed Web of Science ®Google Scholar
• Cuneo A, Roberti MG, Bigoni R, . Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21. Br J Haematol 2000;108:559–564.
   PubMed Web of Science ®Google Scholar
• Qiu HX, Xu W, Cao XS, . Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation. Leuk Lymphoma 2008;49:1887–1892.
   PubMed Web of Science ®Google Scholar
• Cavazzini F, Hernandez JA, Gozzetti A, . Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. Br J Haematol 2008;142:529–523.
   PubMed Web of Science ®Google Scholar
• Haferlach C, Dicker F, Weiss T, . Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters. Genes Chromosomes Cancer 2010;49:851–859.
   PubMed Web of Science ®Google Scholar
• Matutes E, Owusu-Ankomah K, Morilla R, . The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640–1645.
   PubMed Web of Science ®Google Scholar
• Cuneo A, Rigolin GM, Bigoni R, . Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. Leukemia 2004;18:476–483.
   PubMed Web of Science ®Google Scholar
• Rigolin GM, Maffei R, Rizzotto L, . Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance. Cancer 2010;116:1926–1937.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Grever M, . National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990–4997.
   PubMed Web of Science ®Google Scholar
• Rai KR, Sawitsky A, Cronkite EP, . Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
   PubMed Web of Science ®Google Scholar
• Deambrogi C, Cresta S, Cerri M, . 14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia. Br J Haematol 2009;144:131–133.
   PubMed Web of Science ®Google Scholar
• Haferlach C, Dicker F, Schnittger S, . Translocation involving the IGH@ locus occur in 3.7% of chronic lymphocytic leukemia and are associated with unmutated IGHV status and shorter time to treatment: a study on 2,135 cases. Blood 2010;116(Suppl. 1): Abstract 1480.
   Google Scholar
• Matutes E, Attygalle A, Wotherspoon A, . Diagnostic issues in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol 2010;23:3–20.
   PubMed Web of Science ®Google Scholar
• Cuneo A, Bardi A, Wlodarska I, . A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma. Leukemia 2001;15:1262–1267.
   PubMed Web of Science ®Google Scholar
• Nowakowski GS, Dewald GW, Hoyer JD, . Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 2005;130:36–42.
   PubMed Web of Science ®Google Scholar
• Nguyen-Khac F, Lesty C, Chapiro E, . Specific chromosomal IG translocations have different prognosis in chronic lymphocytic leukemia. Blood 2010;116(Suppl. 1): Abstract 582.
   Google Scholar
• Messmer BT, Messmer D, Allen SL, . In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005;115:755–764.
   PubMed Web of Science ®Google Scholar
• van Gent R, Kater AP, Otto SA, . In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow. Cancer Res 2008;68:10137–10144.
   PubMed Web of Science ®Google Scholar
• Herishanu Y, Pérez-Galán P, Liu D, . The lymph node microenvironment promotes B-cell receptor signaling, NF-{kappa}B activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2011;117:563–574.
   PubMed Web of Science ®Google Scholar
• Flanagan MB, Sathanoori M, Surti U, . Cytogenetic abnormalities detected by fluorescence in situ hybridization on paraffin-embedded chronic lymphocytic leukemia/small lymphocytic lymphoma lymphoid tissue biopsy specimens. Am J Clin Pathol 2008;130:620–627.
   PubMed Web of Science ®Google Scholar
• Chesi M, Kuehl WM, Bergsagel PL. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma. Ann Oncol 2000;11(Suppl. 1):131–135.
   PubMed Web of Science ®Google Scholar
• Pospisilova H, Baens M, Michaux L, . Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL. Leukemia 2007;21:2079–2083.
   PubMed Web of Science ®Google Scholar
• Wlodarska I, Matthews C, Veyt E, . Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events. J Mol Diagn 2007;9:47–54.
   PubMed Web of Science ®Google Scholar
• Reindl L, Bacher U, Dicker F, . Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms. Br J Haematol 2010;151:25–36.
   PubMed Web of Science ®Google Scholar